The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma

Conclusion The favourable activity of DEVEC compared to a real-life series and the convenience of an oral administration, may possibly lay the groundwork for a paradigm-shift in the treatment of elderly DLBCL.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research